Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more
Nureca Limited (NURECA) - Total Liabilities
Latest total liabilities as of September 2025: ₹259.46 Million INR
Based on the latest financial reports, Nureca Limited (NURECA) has total liabilities worth ₹259.46 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nureca Limited - Total Liabilities Trend (2017–2025)
This chart illustrates how Nureca Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nureca Limited Competitors by Total Liabilities
The table below lists competitors of Nureca Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bolt Biotherapeutics
NASDAQ:BOLT
|
USA | $32.95 Million |
|
PARKER-HANNIFIN CO. - Dusseldorf Stock Exchang
DU:PAR
|
Germany | €16.70 Billion |
|
Profusa, Inc. Common Stock
NASDAQ:PFSA
|
USA | $38.21 Million |
|
Equites Property Fund Ltd
JSE:EQU
|
South Africa | ZAC12.99 Billion |
|
Lipum AB
ST:LIPUM
|
Sweden | Skr11.63 Million |
|
Noble Helium Ltd
AU:NHE
|
Australia | AU$11.07 Million |
|
Levinstein Eng
TA:LEVI
|
Israel | ILA2.18 Billion |
Liability Composition Analysis (2017–2025)
This chart breaks down Nureca Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nureca Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nureca Limited (2017–2025)
The table below shows the annual total liabilities of Nureca Limited from 2017 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹156.91 Million | +30.17% |
| 2024-03-31 | ₹120.54 Million | +3.05% |
| 2023-03-31 | ₹116.97 Million | -26.58% |
| 2022-03-31 | ₹159.32 Million | -29.67% |
| 2021-03-31 | ₹226.54 Million | +19.55% |
| 2020-03-31 | ₹189.49 Million | +26.51% |
| 2019-03-31 | ₹149.78 Million | +182.66% |
| 2018-03-31 | ₹52.99 Million | +7203.14% |
| 2017-03-31 | ₹725.58K | -- |